METHOTREXATE SODIUM
ALEMBIC · METHOTREXATE SODIUM
Open FDA's page for this record- Application number
- ANDA217552
- Sponsor name
- ALEMBIC
- Submissions
- Submission type
- SUPPL
- Submission number
- 5
- Submission status
- AP
- Submission status date
- 20260527
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20240603
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- METHOTREXATE SODIUM
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- METHOTREXATE SODIUM
- Strength
- EQ 2.5MG BASE
- Harmonized identifiers (openFDA)
- Application number
- ANDA217552
- Brand name
- METHOTREXATE
- Generic name
- METHOTREXATE
- Manufacturer name
- Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited
- Product NDC
- 62332-730, 46708-730
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- METHOTREXATE SODIUM
- RxCUI
- 105585
- SPL ID
- 9dd138d6-6889-400e-a994-9931af68244a, ff55c573-dc84-4ff3-9d10-2b24c47dd679
- SPL set ID
- 04a95db9-a124-4b97-bd71-1c37a6b3b0c8, ff55c573-dc84-4ff3-9d10-2b24c47dd679
- Package NDC
- 62332-730-36, 62332-730-31, 46708-730-36, 46708-730-31
- UNII
- 3IG1E710ZN
